The Effect of Ginger (Zingiber officinalis) and Artichoke (Cynara cardunculus) Extract Supplementation on Functional Dyspepsia: A Randomised, Double-Blind, and Placebo-Controlled Clinical Trial
Attilio Giacosa, Davide Guido, Mario Grassi, Antonella Riva, Paolo Morazzoni, Ezio Bombardelli, Simone Perna, Milena A Faliva, Mariangela Rondanelli, Attilio Giacosa, Davide Guido, Mario Grassi, Antonella Riva, Paolo Morazzoni, Ezio Bombardelli, Simone Perna, Milena A Faliva, Mariangela Rondanelli
Abstract
Objective. Functional dyspepsia (FD) is a frequent clinical finding in western world. The aim of this study is to compare the efficacy of a ginger and artichoke supplementation versus placebo in the treatment of FD. Methods. A prospective multicentre, double blind, randomized, placebo controlled, parallel-group comparison of the supplement and placebo over a period of 4 weeks was performed. Two capsules/day were supplied (before lunch and dinner) to 126 FD patients (supplementation/placebo: 65/61). Results. After 14 days of treatment, only supplementation group (SG) showed a significant amelioration (SG: α S = +1.195 MCA score units (u), P = 0.017; placebo: α P = +0.347 u, P = 0.513). The intercept (α) resulted to be significantly higher in SG than in placebo (α S - α P = +0.848 u, P < 0.001). At the end of the study, the advantage of SG versus placebo persists without variation (β S - β P = +0.077 u, P = 0.542). In SG, a significant advantage is observed for nausea (β S - β P = -0.398 u, P < 0.001), epigastric fullness (β S - β P = -0.241, P < 0.001), epigastric pain (β S - β P = -0.173 u, P = 0.002), and bloating (β S - β P = -0.167 u, P = 0.017). Conclusions. The association between ginger and artichoke leaf extracts appears safe and efficacious in the treatment of FD and could represent a promising treatment for this disease.
Figures
References
- Camilleri M., Dubois D., Coulie B., et al. Prevalence and socioeconomic impact of upper gastrointestinal disorders in the United States: results of the US upper gastrointestinal study. Clinical Gastroenterology and Hepatology. 2005;3(6):543–552. doi: 10.1016/s1542-3565(05)00153-9.
- Knill R. P., Jones R. P. Geografical differences in the prevalence of dyspepsia. Scandinavian Journal of Gastroenterology. 1991;26:17–24.
- Talley N. J., Zinsmeister A. R., Schleck C. D., Melton L. J., III Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology. 1992;102(4):1259–1268.
- Holtmann G. E. H., Goebell H., Talley N. J. Dyspepsia in consulters and non-consulters: prevalence, health-care seeking behaviour and risk factors. European Journal of Gastroenterology and Hepatology. 1994;6(10):917–924. doi: 10.1097/00042737-199410000-00014.
- Talley N. J., Stanghellini V., Heading R. C., Koch K. L., Malagelada J. R., Tytgat G. N. Functional gastroduodenal disorders. Gut. 1999;45(2):1137–1142.
- Ford A. C., Bercik P., Morgan D. G., Bolino C., Pintos-Sanchez M. I., Moayyedi P. The Rome III criteria for the diagnosis of functional dyspepsia in secondary care are not superior to previous definitions. Gastroenterology. 2014;146(4):932–940. doi: 10.1053/j.gastro.2014.01.014.
- Mahadeva S., Goh K. L. Epidemiology of dyspepsia: a global perspective. World Journal of Gastroenterology. 2006;12(17):2661–2666.
- Haag S., Talley N. J., Holtmann G. Symptom patterns in functional dyspepsia and irritable bowel syndrome: relationship to disturbances in gastric emptying and response to a nutrient challenge in consulters and non-consulters. Gut. 2004;53(10):1445–1451. doi: 10.1136/gut.2003.030049.
- Stanghellini V., de Ponti F., de Giorgio R., Barbara G., Tosetti C., Corinaldesi R. New developments in the treatment of functional dyspepsia. Drugs. 2003;63(9):869–892. doi: 10.2165/00003495-200363090-00003.
- Talley N. J. Dyspepsia: management guidelines for the millennium. Gut. 2002;50(4):iv72–iv78.
- Micklefield G. H., Redeker Y., Meister V., Jung O., Greving I., May B. Effects of ginger on gastroduodenal motility. International Journal of Clinical Pharmacology and Therapeutics. 1999;37(7):341–346.
- Ernst E., Pittler M. H. Efficacy of ginger for nausea and vomiting: a systematic review of randomized clinical trials. British Journal of Anaesthesia. 2000;84(3):367–371. doi: 10.1093/oxfordjournals.bja.a013442.
- Holtmann G., Adam B., Haag S., Collet W., Grünewald E., Windeck T. Efficacy of artichoke leaf extract in the treatment of patients with functional dyspepsia: a six-week placebo-controlled, double-blind, multicentre trial. Alimentary Pharmacology & Therapeutics. 2003;18(11-12):1099–1105. doi: 10.1046/j.1365-2036.2003.01767.x.
- Talley N. J., Colin-Jones D., Koch K. L., et al. Functional dyspepsia. A classification with guidelines for diagnosis and management. Gastroenterology International. 1991;4:145–160.
- Talley N. J., Haque M., Wyeth J. W., et al. Development of a new dyspepsia impact scale: the Nepean Dyspepsia Index. Alimentary Pharmacology & Therapeutics. 1999;13(2):225–235. doi: 10.1046/j.1365-2036.1999.00445.x.
- World Medical Association. World Medical Association Declaration of Helsinki. Ethical Principles of Medical Research Involving Human Subjects (2013 revision) Ferney-Voltaire, France: World Medical Association; 2004.
- Likert R. A technique for the measurement of attitudes. Archives of Psychology. 1932;140:1–55.
- Lohelin J. C. Latent Variable Models: An Introduction to Factor, Path and Structural Equation Analysis. New York, NY, USA: Lawrence Erlbaum Associates; 2004.
- Mair P., de Leeuw J. A general framework for multivariate analysis with optimal scaling: the R package aspect. Journal of Statistical Software. 2010;32(9):1–23.
- Bagozzi R. P., Yi Y. Specification, evaluation, and interpretation of structural equation models. Journal of the Academy of Marketing Science. 2012;40(1):8–34. doi: 10.1007/s11747-011-0278-x.
- Rosseel Y. Lavaan: an R package for structural equation modeling. Journal of Statistical Software. 2012;48(2):1–36.
- R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2013.
- Dobrilla G., Comberlato M., Steele A., Vallaperta P. Drug treatment of functional dyspepsia. A meta-analysis of randomized controlled clinical trials. Journal of Clinical Gastroenterology. 1989;11(2):169–177. doi: 10.1097/00004836-198904000-00011.
- Futagami S., Shimpuku M., Yin Y., et al. Pathophysiology of functional dyspepsia. Journal of Nippon Medical School. 2011;78(5):280–285. doi: 10.1272/jnms.78.280.
- Committee on Herbal Medicinal Products. Assessment report on Zingiber officinale Roscoe, rhizome. European Medicines Agency. 2011;(EMA/HMPC/577856/2010)
- Wu K.-L., Rayner C. K., Chuah S.-K., et al. Effects of ginger on gastric emptying and motility in healthy humans. European Journal of Gastroenterology & Hepatology. 2008;20(5):436–440. doi: 10.1097/meg.0b013e3282f4b224.
- Ali B. H., Blunden G., Tanira M. O., Nemmar A. Some phytochemical, pharmacological and toxicological properties of ginger (Zingiber officinale Roscoe): a review of recent research. Food and Chemical Toxicology. 2008;46(2):409–420. doi: 10.1016/j.fct.2007.09.085.
- Gebhardt R., Fausel M. Antioxidant and hepatoprotective effects of artichoke extracts and constituents in cultured rat hepatocytes. Toxicology in Vitro. 1997;11(5):669–672. doi: 10.1016/s0887-2333(97)00078-7.
- Gebhardt R. Inhibition of hepatic cholesterol biosynthesis by artichoke leaf extracts is mainly due to luteolin. Cell Biology and Toxicology. 1997;13:p. 58.
- Brown J. E., Rice-Evans C. A. Luteolin-rich artichoke extract protects low density lipoprotein from oxidation in vitro . Free Radical Research. 1998;29(3):247–255. doi: 10.1080/10715769800300281.
- Pérez-García F., Adzet T., Cañigueral S. Activity of artichoke leaf extract on reactive oxygen species in human leukocytes. Free Radical Research. 2000;33(5):661–665. doi: 10.1080/10715760000301171.
- Rechner A. R., Pannala A. S., Rice-Evans C. A. Caffeic acid derivatives in artichoke extract are metabolised to phenolic acids in vivo. Free Radical Research. 2001;35(2):195–202. doi: 10.1080/10715760100300741.
- Ishida K., Kojima R., Tsuboi M., Tsuda Y., Ito M. Effects of artichoke leaf extract on acute gastric mucosal injury in rats. Biological and Pharmaceutical Bulletin. 2010;33(2):223–229. doi: 10.1248/bpb.33.223.
- Emendörfer F., Bellato F., Noldin V. F., et al. Antispasmodic activity of fractions and cynaropicrin from Cynara scolymus on guinea-pig ileum. Biological and Pharmaceutical Bulletin. 2005;28(5):902–904. doi: 10.1248/bpb.28.902.
- Ding M., Leach M., Bradley H. The effectiveness and safety of ginger for pregnancy-induced nausea and vomiting: a systematic review. Women and Birth. 2013;26(1):e26–e30. doi: 10.1016/j.wombi.2012.08.001.
- Ryan J. L., Heckler C. E., Roscoe J. A., et al. Ginger (Zingiber officinale) reduces acute chemotherapy-induced nausea: a URCC CCOP study of 576 patients. Supportive Care in Cancer. 2012;20(7):1479–1489. doi: 10.1007/s00520-011-1236-3.
- Thomson M., Corbin R., Leung L. Effects of ginger for nausea and vomiting in early pregnancy: a meta-analysis. Journal of the American Board of Family Medicine. 2014;27(1):115–122. doi: 10.3122/jabfm.2014.01.130167.
- Kirchhoff R., Beckers C., Kirchhoff G., Trinczek-Gärtner H., Petrowicz O., Reimann H. Increase in choleresis by means of artichoke extract. Results of a randomized placebo-controlled double blind study. Phytomedicine. 1994;1(2):107–115. doi: 10.1016/s0944-7113(11)80027-9.
- Aggarwal A., Bhatt M. Commonly used gastrointestinal drugs. Handbook of Clinical Neurology. 2014;120:633–643. doi: 10.1016/b978-0-7020-4087-0.00043-7.
- van Roeden S. E., Belle-van Meerkerk G., van Tuyl S. A. C., van De Ree M. A., Muller A. F. Domperidone and the risk of sudden cardiac death. Nederlands Tijdschrift voor Geneeskunde. 2013;157(46)A6770
- Hondeghem L. M. Domperidone: limited benefits with significant risk for sudden cardiac death. Journal of Cardiovascular Pharmacology. 2013;61(3):218–225. doi: 10.1097/fjc.0b013e31827afd0d.
- Michaud V., Turgeon J. Domperidone and sudden cardiac death: how much longer should we wait? Journal of Cardiovascular Pharmacology. 2013;61(3):215–217. doi: 10.1097/fjc.0b013e31827e2573.
- Kanji S., Stevenson A., Hutton B. Sudden cardiac death and ventricular arrhythmias associated with domperidone: evidence supporting health Canada’s warning. The Canadian Journal of Hospital Pharmacy. 2014;67(4):311–312. doi: 10.4212/cjhp.v67i4.1378.
Source: PubMed